Skip to main content
Erschienen in: European Journal of Epidemiology 10/2007

01.10.2007 | Renal Disease

Metabolic risk factors associated with serum creatinine in a non-diabetic population

verfasst von: Jens Kronborg, Trond Jenssen, Inger Njølstad, Ingrid Toft, Bjørn O. Eriksen

Erschienen in: European Journal of Epidemiology | Ausgabe 10/2007

Einloggen, um Zugang zu erhalten

Abstract

Insulin resistance, low HDL-cholesterol and microalbuminuria are important components of the metabolic syndrome as defined by WHO. Insulin resistance and low HDL-cholesterol are also common in chronic kidney disease (CKD), but it is not clear whether they are early or late phenomenons in the development of renal failure. This study examined whether low-grade albuminuria (microalbuminuria), lipoprotein fractions, and the insulin/glucose ratio (IGR)—a surrogate marker of insulin resistance—were related to renal function (expressed as serum creatinine) in persons without diabetes and with apparently normal renal function. The study included 4,131 men and women aged 55–75 years from the cross-sectional Tromsø IV survey (1994–1995). Lifestyle factors, waist circumference and blood pressure were included in the analyses. Gender stratified multivariate analysis was used to assess the relationship between serum creatinine and microalbuminuria, lipoprotein fractions and IGR. Serum creatinine was positively associated with microalbuminuria in men (β = 2.50, 95% confidence interval (CI) 0.66–4.34), but not in women. HDL-cholesterol and IGR were strongly associated with creatinine in both genders (HDL-cholesterol: Men: β = −4.82, 95% CI −6.27 to −3.37; women: β = −2.12, 95% CI −3.28 to −0.96. IGR: Second, third and fourth quartile compared with first quartile, men: β = 0.94, 95% CI −0.63 to 2.51; 2.10, 95% CI 0.52–3.69 and 2.40, 95% CI 0.75–4.04; women: β = 1.91, 95% CI 0.59–3.22; 2.61, 95% CI 1.28–3.95 and 3.20, 95% CI 1.80–4.60). These findings suggest that even early impairment of renal function may be associated with insulin resistance and dyslipidemia, regardless of renal albumin leakage.
Literatur
1.
Zurück zum Zitat Muntner P, Coresh J, Smith JC, Eckfeldt J, Klag MJ. Plasma lipids and risk of developing renal dysfunction: the atherosclerosis risk in communities study. Kidney Int 2000;58(1):293–301.PubMedCrossRef Muntner P, Coresh J, Smith JC, Eckfeldt J, Klag MJ. Plasma lipids and risk of developing renal dysfunction: the atherosclerosis risk in communities study. Kidney Int 2000;58(1):293–301.PubMedCrossRef
2.
Zurück zum Zitat Mänttäri M, Tiula E, Alikoski T, Manninen V. Effects of hypertension and dyslipidemia on the decline in renal function. Hypertension 1995;26(4):670–5.PubMed Mänttäri M, Tiula E, Alikoski T, Manninen V. Effects of hypertension and dyslipidemia on the decline in renal function. Hypertension 1995;26(4):670–5.PubMed
3.
Zurück zum Zitat The Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 1993;329(14):977–86. The Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 1993;329(14):977–86.
4.
Zurück zum Zitat Mogensen CE. Microalbuminuria predicts clinical proteinuria and early mortality in maturity-onset diabetes. N Engl J Med 1984;310(6):356–60.PubMedCrossRef Mogensen CE. Microalbuminuria predicts clinical proteinuria and early mortality in maturity-onset diabetes. N Engl J Med 1984;310(6):356–60.PubMedCrossRef
5.
Zurück zum Zitat Borch-Johnsen K, Feldt-Rasmussen B, Strandgaard S, Schroll M, Jensen JS. Urinary albumin excretion. An independent predictor of ischemic heart disease. Arterioscler Thromb Vasc Biol 1999;19(8):1992–7.PubMed Borch-Johnsen K, Feldt-Rasmussen B, Strandgaard S, Schroll M, Jensen JS. Urinary albumin excretion. An independent predictor of ischemic heart disease. Arterioscler Thromb Vasc Biol 1999;19(8):1992–7.PubMed
6.
Zurück zum Zitat Alberti KG, Zimmet PZ. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet Med 1998;15(7):539–53.PubMedCrossRef Alberti KG, Zimmet PZ. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet Med 1998;15(7):539–53.PubMedCrossRef
7.
Zurück zum Zitat Boden G. Pathogenesis of type 2 diabetes. Insulin resistance. Endocrinol Metab Clin North Am 2001;30(4):801–15.PubMedCrossRef Boden G. Pathogenesis of type 2 diabetes. Insulin resistance. Endocrinol Metab Clin North Am 2001;30(4):801–15.PubMedCrossRef
8.
Zurück zum Zitat Ginsberg HN. Insulin resistance and cardiovascular disease. J Clin Invest 2000;106(4):453–8.PubMedCrossRef Ginsberg HN. Insulin resistance and cardiovascular disease. J Clin Invest 2000;106(4):453–8.PubMedCrossRef
9.
Zurück zum Zitat Chen J, Muntner P, Hamm LL, Fonseca V, Batuman V, Whelton PK, et al. Insulin resistance and risk of chronic kidney disease in nondiabetic US adults. J Am Soc Nephrol 2003;14(2):469–77.PubMedCrossRef Chen J, Muntner P, Hamm LL, Fonseca V, Batuman V, Whelton PK, et al. Insulin resistance and risk of chronic kidney disease in nondiabetic US adults. J Am Soc Nephrol 2003;14(2):469–77.PubMedCrossRef
10.
Zurück zum Zitat Kurella M, Lo JC, Chertow GM. Metabolic syndrome and the risk for chronic kidney disease among nondiabetic adults. J Am Soc Nephrol 2005;16(7):2134–40.PubMedCrossRef Kurella M, Lo JC, Chertow GM. Metabolic syndrome and the risk for chronic kidney disease among nondiabetic adults. J Am Soc Nephrol 2005;16(7):2134–40.PubMedCrossRef
11.
Zurück zum Zitat Van Biesen W, Vanholder R, Veys N, Verbeke F, Delanghe J, De Bacquer D, et al. The importance of standardization of creatinine in the implementation of guidelines and recommendations for CKD: implications for CKD management programmes. Nephrol Dial Transplant 2006;21(1):77–83.PubMedCrossRef Van Biesen W, Vanholder R, Veys N, Verbeke F, Delanghe J, De Bacquer D, et al. The importance of standardization of creatinine in the implementation of guidelines and recommendations for CKD: implications for CKD management programmes. Nephrol Dial Transplant 2006;21(1):77–83.PubMedCrossRef
12.
Zurück zum Zitat Jorde R, Burhol PG, Schulz TB, Waldum HL, Lygren I, Jenssen T, et al. The effect of a 34-h fast on the meal-induced rises in plasma GIP, serum insulin, and blood glucose in man. Scand J Gastroenterol 1981;16(1):109–12.PubMed Jorde R, Burhol PG, Schulz TB, Waldum HL, Lygren I, Jenssen T, et al. The effect of a 34-h fast on the meal-induced rises in plasma GIP, serum insulin, and blood glucose in man. Scand J Gastroenterol 1981;16(1):109–12.PubMed
13.
Zurück zum Zitat He J, Klag MJ, Caballero B, Appel LJ, Charleston J, Whelton PK. Plasma insulin levels and incidence of hypertension in African Americans and whites. Arch Intern Med 1999;159(5):498–503.PubMedCrossRef He J, Klag MJ, Caballero B, Appel LJ, Charleston J, Whelton PK. Plasma insulin levels and incidence of hypertension in African Americans and whites. Arch Intern Med 1999;159(5):498–503.PubMedCrossRef
14.
Zurück zum Zitat Sullivan CS, Beste J, Cummings DM, Hester VH, Holbrook T, Kolasa KM, et al. Prevalence of hyperinsulinemia and clinical correlates in overweight children referred for lifestyle intervention. J Am Diet Assoc 2004;104(3):433–6.PubMedCrossRef Sullivan CS, Beste J, Cummings DM, Hester VH, Holbrook T, Kolasa KM, et al. Prevalence of hyperinsulinemia and clinical correlates in overweight children referred for lifestyle intervention. J Am Diet Assoc 2004;104(3):433–6.PubMedCrossRef
15.
Zurück zum Zitat Verhave JC, Hillege HL, Burgerhof JG, Gansevoort RT, de Zeeuw D, de Jong PE. The association between atherosclerotic risk factors and renal function in the general population. Kidney Int 2005;67(5):1967–73.PubMedCrossRef Verhave JC, Hillege HL, Burgerhof JG, Gansevoort RT, de Zeeuw D, de Jong PE. The association between atherosclerotic risk factors and renal function in the general population. Kidney Int 2005;67(5):1967–73.PubMedCrossRef
16.
Zurück zum Zitat Schaeffner ES, Kurth T, Curhan GC, Glynn RJ, Rexrode KM, Baigent C, et al. Cholesterol and the risk of renal dysfunction in apparently healthy men. J Am Soc Nephrol 2003;14(8):2084–91.PubMed Schaeffner ES, Kurth T, Curhan GC, Glynn RJ, Rexrode KM, Baigent C, et al. Cholesterol and the risk of renal dysfunction in apparently healthy men. J Am Soc Nephrol 2003;14(8):2084–91.PubMed
17.
Zurück zum Zitat Rubins HB, Robins SJ, Collins D, Fye CL, Anderson JW, Elam MB, et al. Gemfibrozil for the secondary prevention of coronary heart disease in men with low levels of high-density lipoprotein cholesterol. Veterans Affairs High-Density Lipoprotein Cholesterol Intervention Trial Study Group. N Engl J Med 1999;341(6):410–8.PubMedCrossRef Rubins HB, Robins SJ, Collins D, Fye CL, Anderson JW, Elam MB, et al. Gemfibrozil for the secondary prevention of coronary heart disease in men with low levels of high-density lipoprotein cholesterol. Veterans Affairs High-Density Lipoprotein Cholesterol Intervention Trial Study Group. N Engl J Med 1999;341(6):410–8.PubMedCrossRef
18.
Zurück zum Zitat Shai I, Rimm EB, Hankinson SE, Curhan G, Manson JE, Rifai N, et al. Multivariate assessment of lipid parameters as predictors of coronary heart disease among postmenopausal women: potential implications for clinical guidelines. Circulation 2004;110(18):2824–30.PubMedCrossRef Shai I, Rimm EB, Hankinson SE, Curhan G, Manson JE, Rifai N, et al. Multivariate assessment of lipid parameters as predictors of coronary heart disease among postmenopausal women: potential implications for clinical guidelines. Circulation 2004;110(18):2824–30.PubMedCrossRef
19.
Zurück zum Zitat Fliser D, Pacini G, Engelleiter R, Kautzky-Willer A, Prager R, Franek E, et al. Insulin resistance and hyperinsulinemia are already present in patients with incipient renal disease. Kidney Int 1998;53(5):1343–7.PubMedCrossRef Fliser D, Pacini G, Engelleiter R, Kautzky-Willer A, Prager R, Franek E, et al. Insulin resistance and hyperinsulinemia are already present in patients with incipient renal disease. Kidney Int 1998;53(5):1343–7.PubMedCrossRef
20.
Zurück zum Zitat Sechi LA, Catena C, Zingaro L, Melis A, De Marchi S. Abnormalities of glucose metabolism in patients with early renal failure. Diabetes 2002;51(4):1226–32.PubMedCrossRef Sechi LA, Catena C, Zingaro L, Melis A, De Marchi S. Abnormalities of glucose metabolism in patients with early renal failure. Diabetes 2002;51(4):1226–32.PubMedCrossRef
21.
Zurück zum Zitat Wannamethee SG, Shaper AG, Durrington PN, Perry IJ. Hypertension, serum insulin, obesity and the metabolic syndrome. J Hum Hypertens 1998;12(11):735–41.PubMedCrossRef Wannamethee SG, Shaper AG, Durrington PN, Perry IJ. Hypertension, serum insulin, obesity and the metabolic syndrome. J Hum Hypertens 1998;12(11):735–41.PubMedCrossRef
22.
Zurück zum Zitat Perry IJ, Wannamethee SG, Shaper AG, Alberti KG. Serum true insulin concentration and the risk of clinical non-insulin dependent diabetes during long-term follow-up. Int J Epidemiol 1999;28(4):735–41.PubMedCrossRef Perry IJ, Wannamethee SG, Shaper AG, Alberti KG. Serum true insulin concentration and the risk of clinical non-insulin dependent diabetes during long-term follow-up. Int J Epidemiol 1999;28(4):735–41.PubMedCrossRef
23.
Zurück zum Zitat Regalado M, Yang S, Wesson DE. Cigarette smoking is associated with augmented progression of renal insufficiency in severe essential hypertension. Am J Kidney Dis 2000;35(4):687–94.PubMed Regalado M, Yang S, Wesson DE. Cigarette smoking is associated with augmented progression of renal insufficiency in severe essential hypertension. Am J Kidney Dis 2000;35(4):687–94.PubMed
24.
Zurück zum Zitat Halimi JM, Giraudeau B, Vol S, Cacès E, Nivet H, Lebranchu Y, et al. Effects of current smoking and smoking discontinuation on renal function and proteinuria in the general population. Kidney Int 2000;58(3):1285–92.PubMedCrossRef Halimi JM, Giraudeau B, Vol S, Cacès E, Nivet H, Lebranchu Y, et al. Effects of current smoking and smoking discontinuation on renal function and proteinuria in the general population. Kidney Int 2000;58(3):1285–92.PubMedCrossRef
25.
Zurück zum Zitat Vikse BE, Vollset SE, Tell GS, Refsum H, Iversen BM. Distribution and determinants of serum creatinine in the general population: the Hordaland Health Study. Scand J Clin Lab Invest 2004;64(8):709–22.PubMedCrossRef Vikse BE, Vollset SE, Tell GS, Refsum H, Iversen BM. Distribution and determinants of serum creatinine in the general population: the Hordaland Health Study. Scand J Clin Lab Invest 2004;64(8):709–22.PubMedCrossRef
26.
Zurück zum Zitat Pinto-Sietsma SJ, Mulder J, Janssen WM, Hillege HL, de Zeeuw D, de Jong PE. Smoking is related to albuminuria and abnormal renal function in nondiabetic persons. Ann Intern Med 2000;133(8):585–91.PubMed Pinto-Sietsma SJ, Mulder J, Janssen WM, Hillege HL, de Zeeuw D, de Jong PE. Smoking is related to albuminuria and abnormal renal function in nondiabetic persons. Ann Intern Med 2000;133(8):585–91.PubMed
27.
Zurück zum Zitat Briganti EM, Branley P, Chadban SJ, Shaw JE, McNeil JJ, Welborn TA, et al. Smoking is associated with renal impairment and proteinuria in the normal population: the AusDiab kidney study. Australian Diabetes, Obesity and Lifestyle Study. Am J Kidney Dis 2002;40(4):704–12.PubMedCrossRef Briganti EM, Branley P, Chadban SJ, Shaw JE, McNeil JJ, Welborn TA, et al. Smoking is associated with renal impairment and proteinuria in the normal population: the AusDiab kidney study. Australian Diabetes, Obesity and Lifestyle Study. Am J Kidney Dis 2002;40(4):704–12.PubMedCrossRef
28.
Zurück zum Zitat Vervoort G, Willems HL, Wetzels JF. Assessment of glomerular filtration rate in healthy subjects and normoalbuminuric diabetic patients: validity of a new (MDRD) prediction equation. Nephrol Dial Transplant 2002;17(11):1909–13.PubMedCrossRef Vervoort G, Willems HL, Wetzels JF. Assessment of glomerular filtration rate in healthy subjects and normoalbuminuric diabetic patients: validity of a new (MDRD) prediction equation. Nephrol Dial Transplant 2002;17(11):1909–13.PubMedCrossRef
Metadaten
Titel
Metabolic risk factors associated with serum creatinine in a non-diabetic population
verfasst von
Jens Kronborg
Trond Jenssen
Inger Njølstad
Ingrid Toft
Bjørn O. Eriksen
Publikationsdatum
01.10.2007
Verlag
Springer Netherlands
Erschienen in
European Journal of Epidemiology / Ausgabe 10/2007
Print ISSN: 0393-2990
Elektronische ISSN: 1573-7284
DOI
https://doi.org/10.1007/s10654-007-9164-8

Weitere Artikel der Ausgabe 10/2007

European Journal of Epidemiology 10/2007 Zur Ausgabe